JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB76040

Anti-CSNK2A1 antibody [EP1963Y]

Be the first to review this product! Submit a review

|

(15 Publications)

Rabbit Recombinant Monoclonal CSNK2A1 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Mouse, Rat, Human samples. Cited in 15 publications.

View Alternative Names

CK2A1, CSNK2A1, Casein kinase II subunit alpha, CK II alpha

6 Images
Flow Cytometry (Intracellular) - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)

Intracellular Flow Cytometry analysis of Jurkat (Human T cell leukemia T lymphocyte) cells labeling CSNK2A1 with purified ab76040 at 1 : 20 dilution (10 μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as a isotype control. Cell without incubation with primary antibody and secondary antibody (Blue) were used as unlabeled control.

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
  • WB

Lab

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)

Lanes 1 - 4 : Merged signal (red and green). Green – ab76040 observed at 45 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab76040 was shown to specifically react with CSNK2A1 when CCSNK2A1 knockout samples were used. Wild-type and CSNK2A1 knockout samples were subjected to SDS-PAGE. ab76040 and ab8245 (loading control to GAPDH) were diluted at 1/500 and 1/10 000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/500 dilution

Lane 1:

Wild-type HAP1 cell lysate at 20 µg

Lane 2:

CSNK2A1 knockout HAP1 cell lysate at 20 µg

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

Jurkat cell lysate at 20 µg

Predicted band size: 45 kDa

false

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
  • WB

Lab

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)

Lanes 1-2 : Merged signal (red and green). Green - ab76040 observed at 45 kDa. Red - loading control ab8245 observed at 37 kDa.

ab76040 Anti-CSNK2A1 antibody [EP1963Y] was shown to specifically react with CSNK2A1 in wild-type HCT116 cells. Loss of signal was observed when knockout cell line ab266864 (knockout cell lysate ab257401) was used. Wild-type and CSNK2A1 knockout samples were subjected to SDS-PAGE. ab76040 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/1000 dilution

Lane 1:

Wild-type HCT116 cell lysate at 20 µg

Lane 2:

CSNK2A1 knockout HCT116 cell lysate at 20 µg

Lane 2:

Western blot - Human CSNK2A1 knockout HCT116 cell line (<a href='/en-us/products/cell-lines/human-csnk2a1-knockout-hct116-cell-line-ab266864'>ab266864</a>)

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
  • WB

Unknown

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)

All lanes:

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/1000 dilution

All lanes:

HeLa cell lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
  • WB

Lab

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

All lanes:

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/1000 dilution

Lane 1:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 15 µg

Lane 2:

Mouse brain lysate at 15 µg

Lane 3:

Rat brian lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 45 kDa

Observed band size: 45 kDa

false

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)
  • WB

Lab

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (AB76040)

ab76040 was shown to react with CSNK2A1 in wild-type HAP1 cells in Western blot with loss of signal observed in a CSNK2A1 knockout cell line. Wild-type HAP1 and CSNK2A1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab76040 overnight at 4 °C at a 1/500 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.

These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-CSNK2A1 antibody [EP1963Y] (ab76040) at 1/500 dilution

Lane 1:

Wild-type HAP1 lysate at 30 µg

Lane 2:

CSNK2A1 knock-out HAP1 lysate at 30 µg

false

  • 660 APC

    APC Anti-CKII alpha antibody [EP1963Y]

  • HRP

    HRP Anti-CKII alpha antibody [EP1963Y]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-CKII alpha antibody [EP1963Y]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-CKII alpha antibody [EP1963Y]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-CKII alpha antibody [EP1963Y]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-CSNK2A1 antibody [EP1963Y]

  • 578 PE

    PE Anti-CKII alpha antibody [EP1963Y]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-CKII alpha antibody [EP1963Y]

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP1963Y

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20 - 1/50", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine (PubMed : 11239457, PubMed : 11704824, PubMed : 16193064, PubMed : 18411307, PubMed : 18583988, PubMed : 18678890, PubMed : 19188443, PubMed : 20545769, PubMed : 20625391, PubMed : 22017874, PubMed : 22406621, PubMed : 24962073, PubMed : 30898438, PubMed : 31439799). Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection (PubMed : 12631575, PubMed : 19387551, PubMed : 19387552). May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response (PubMed : 12631575, PubMed : 19387551, PubMed : 19387552). During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage (PubMed : 11704824, PubMed : 19188443). Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation (PubMed : 11239457). Phosphorylates a number of DNA repair proteins in response to DNA damage, such as MDC1, MRE11, RAD9A, RAD51 and HTATSF1, promoting their recruitment to DNA damage sites (PubMed : 18411307, PubMed : 18583988, PubMed : 18678890, PubMed : 20545769, PubMed : 21482717, PubMed : 22325354, PubMed : 26811421, PubMed : 28512243, PubMed : 30898438, PubMed : 35597237). Can also negatively regulate apoptosis (PubMed : 16193064, PubMed : 22184066). Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3 (PubMed : 16193064). Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8 (PubMed : 16193064). Phosphorylates YY1, protecting YY1 from cleavage by CASP7 during apoptosis (PubMed : 22184066). Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV (PubMed : 12631575, PubMed : 19387550, PubMed : 19387551, PubMed : 19387552, PubMed : 23123191). Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, ATF4, SRF, MAX, JUN, FOS, MYC and MYB (PubMed : 12631575, PubMed : 19387550, PubMed : 19387551, PubMed : 19387552, PubMed : 23123191). Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function (PubMed : 19387550). Mediates sequential phosphorylation of FNIP1, promoting its gradual interaction with Hsp90, leading to activate both kinase and non-kinase client proteins of Hsp90 (PubMed : 30699359). Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1 (PubMed : 19387549). Acts as an ectokinase that phosphorylates several extracellular proteins (PubMed : 12631575, PubMed : 19387550, PubMed : 19387551, PubMed : 19387552). During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV (PubMed : 12631575, PubMed : 19387550, PubMed : 19387551, PubMed : 19387552). Phosphorylates PML at 'Ser-565' and primes it for ubiquitin-mediated degradation (PubMed : 20625391, PubMed : 22406621). Plays an important role in the circadian clock function by phosphorylating BMAL1 at 'Ser-90' which is pivotal for its interaction with CLOCK and which controls CLOCK nuclear entry (By similarity). Phosphorylates CCAR2 at 'Thr-454' in gastric carcinoma tissue (PubMed : 24962073). Phosphorylates FMR1, promoting FMR1-dependent formation of a membraneless compartment (PubMed : 30765518, PubMed : 31439799). May phosphorylate histone H2A on 'Ser-1' (PubMed : 38334665).
See full target information CSNK2A1

Publications (15)

Recent publications for all applications. Explore the full list and refine your search

International journal of molecular medicine 56: PubMed40927979

2025

Pharmacological inhibition of casein kinase II attenuates metaflammation in a murine model of diet‑induced metabolic dysfunction.

Applications

Unspecified application

Species

Unspecified reactive species

Elisa Porchietto,Eleonora Aimaretti,Giacomo Einaudi,Gustavo Ferreira Alves,Debora Collotta,Enrica Marzani,Leonardo Camillò,Chiara Rubeo,Raffaella Mastrocola,Natasha Irrera,Manuela Aragno,Carlo Cifani,Massimo Collino

Clinical, cosmetic and investigational dermatology 18:1971-1983 PubMed40860313

2025

Ellagic Acid Mediates the Delay of Dermal Fibroblast Senescence via CSNK2A1.

Applications

Unspecified application

Species

Unspecified reactive species

Ziwei Zhang,Pu Yang,Yang Sun,Xinhai Yu,Xiangyu Chen,Xiancheng Wang

F1000Research 13:781 PubMed39403680

2024

A guide to selecting high-performing antibodies for CSNK2A1 (UniProt ID: P68400) for use in western blot, immunoprecipitation and immunofluorescence.

Applications

WB, ICC

Species

Human, Human

Riham Ayoubi,Maryam Fotouhi,Charles Alende,Vera Ruíz Moleón,Kathleen Southern,Carl Laflamme

Nature cardiovascular research 2:835-852 PubMed38075556

2023

Critical shifts in lipid metabolism promote megakaryocyte differentiation and proplatelet formation.

Applications

Unspecified application

Species

Unspecified reactive species

Bianca de Jonckheere,Ferdinand Kollotzek,Patrick Münzer,Vanessa Göb,Melina Fischer,Kristina Mott,Cristina Coman,Nina Nicole Troppmair,Mailin-Christin Manke,Monika Zdanyte,Tobias Harm,Manuel Sigle,Dominik Kopczynski,Andrea Bileck,Christopher Gerner,Nils Hoffmann,David Heinzmann,Alice Assinger,Meinrad Gawaz,David Stegner,Harald Schulze,Oliver Borst,Robert Ahrends

The EMBO journal 42:e114051 PubMed38059508

2023

CDK11 requires a critical activator SAP30BP to regulate pre-mRNA splicing.

Applications

Unspecified application

Species

Unspecified reactive species

Changshou Wang,Lin Xu,Chen Du,Hao Yun,Keyun Wang,Hui Liu,Mingliang Ye,Jing Fan,Yu Zhou,Hong Cheng

Journal of immunology (Baltimore, Md. : 1950) 209:896-906 PubMed35914835

2022

Protein Kinase CK2 Controls CD8 T Cell Effector and Memory Function during Infection.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Yang,Hairong Wei,Gloria A Benavides,William J Turbitt,Jessica A Buckley,Xiaosen Ouyang,Lianna Zhou,Jianhua Zhang,Laurie E Harrington,Victor M Darley-Usmar,Hongwei Qin,Etty N Benveniste

Frontiers in cellular neuroscience 16:911973 PubMed35928572

2022

Casein kinase 2 attenuates brain injury induced by intracerebral hemorrhage via regulation of NR2B phosphorylation.

Applications

Unspecified application

Species

Unspecified reactive species

Zhimin Sun,Qiyao Li,Xiaopeng Li,Yunpeng Shi,Chengrui Nan,Qianxu Jin,Xiaoyan Wang,Yayu Zhuo,Zongmao Zhao

PeerJ 9:e12519 PubMed34993017

2021

Identification of high protein kinase CK2α in HPV(+) oropharyngeal squamous cell carcinoma and correlation with clinical outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Janeen H Trembley,Bin Li,Betsy T Kren,Justin Peltola,Juan Manivel,Devi Meyyappan,Amy Gravely,Mark Klein,Khalil Ahmed,Emiro Caicedo-Granados

Nature communications 12:4671 PubMed34344863

2021

Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease.

Applications

Unspecified application

Species

Unspecified reactive species

Katsutoshi Sato,Amol A Padgaonkar,Stacey J Baker,Stephen C Cosenza,Olga Rechkoblit,D R C Venkata Subbaiah,Josep Domingo-Domenech,Alison Bartkowski,Elisa R Port,Aneel K Aggarwal,M V Ramana Reddy,Hanna Y Irie,E Premkumar Reddy

Cancer management and research 11:10135-10143 PubMed31819646

2019

CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Jiang,Zhenghong Ma,Guoan Zhang,Xigui Yang,Qin Du,Weibo Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com